These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5012489)

  • 21. Polyinosinic acid-polycytidylic acid in ophthalmology. II. Systemic absorption after topical ocular, intravenous, and intraocular administration in rabbits.
    McDonald TO; Borgmann AR
    Ann Ophthalmol; 1971 Oct; 3(10):1135-9. PubMed ID: 5163794
    [No Abstract]   [Full Text] [Related]  

  • 22. The influence of polyinosinic-polycytidylic acid complex on vaccinia keratitis in rabbits.
    Chowchuvech E; Weissenbacher M; Galin MA; Baron S
    Invest Ophthalmol; 1970 Sep; 9(9):716-21. PubMed ID: 5451003
    [No Abstract]   [Full Text] [Related]  

  • 23. Polyinosinic acid-polycytidylic acid in ophthalmology. I. Ocular irritation studies in rabbits.
    McDonald TO; Fox LG; Timberlake GM; Belluscio PR; Borgmann AR
    Ann Ophthalmol; 1971 Apr; 3(4):371-6. PubMed ID: 5163962
    [No Abstract]   [Full Text] [Related]  

  • 24. [Extensive toxoplasmic retinochoroiditis. Diagnostic and therapeutic management].
    Theaudin M; Bodaghi B; Cassoux N; Romand S; Le Mer Y; Lemaitre C; Fardeau C; Thulliez P; LeHoang P
    J Fr Ophtalmol; 2003 Nov; 26(9):921-7. PubMed ID: 14631276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features of toxoplasmic retinochoroiditis in patients with acquired immunodeficiency syndrome.
    Pivetti-Pezzi P; Accorinti M; Tamburi S; Ciapparoni V; Abdulaziz MA
    Ann Ophthalmol; 1994; 26(3):73-84. PubMed ID: 7944160
    [No Abstract]   [Full Text] [Related]  

  • 26. [Interest in treatment with subconjunctival clindamycin in toxoplasmic retinochoroiditis].
    Ben Zina Z; Abid D; Kharrat W; Chaker N; Aloulou K; Chaâbouni M
    Tunis Med; 2001 Mar; 79(3):157-60. PubMed ID: 11471444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The treatment of toxoplasmic posterior uveitis (chorioretinitis).
    Giles CL
    Am J Med Sci; 1966 Feb; 251(2):241-2. PubMed ID: 5295371
    [No Abstract]   [Full Text] [Related]  

  • 28. Reactivation of toxoplasma retinochoroiditis under atovaquone therapy in an immunocompetent patient.
    Baatz H; Mirshahi A; Puchta J; Gümbel H; Hattenbach LO
    Ocul Immunol Inflamm; 2006 Jun; 14(3):185-7. PubMed ID: 16766403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis.
    McLeod R; Khan AR; Noble GA; Latkany P; Jalbrzikowski J; Boyer K;
    Pediatr Infect Dis J; 2006 Mar; 25(3):270-2. PubMed ID: 16511396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polyinosinic acid-polycytidylic acid in ophthalmology. 3. Intraocular response after intravenous, intraocular, and topical ocular administration in rabbits.
    McDonald TO; Borgmann AR
    Ann Ophthalmol; 1971 Oct; 3(10):1146-51. PubMed ID: 5163795
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of immunization with attenuated Mycobacterium bovis on experimental toxoplasmic retinochoroiditis.
    Tabbara KJ; O'Connor GR; Nozik RA
    Am J Ophthalmol; 1975 Apr; 79(4):641-7. PubMed ID: 1119523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Manifestations and management of ocular toxoplasmosis.
    O'Connor GR
    Bull N Y Acad Med; 1974 Feb; 50(2):192-210. PubMed ID: 4521729
    [No Abstract]   [Full Text] [Related]  

  • 33. Increased serum levels of CXCL8 chemokine in acute toxoplasmic retinochoroiditis.
    Gonçalves RM; Rodrigues DH; Camargos da Costa AM; Teixeira MM; Ribeiro Campos W; Oréfice F; Teixeira AL
    Acta Ophthalmol Scand; 2007 Dec; 85(8):871-6. PubMed ID: 17488320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does atovaquone prolong the disease-free interval of toxoplasmic retinochoroiditis?
    Winterhalter S; Severing K; Stammen J; Maier AK; Godehardt E; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2010 Aug; 248(8):1187-92. PubMed ID: 20437247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scleritis associated with toxoplasmic retinochoroiditis.
    Rudich DS; Bhatnagar P
    Arch Ophthalmol; 2012 May; 130(5):659-60. PubMed ID: 22652859
    [No Abstract]   [Full Text] [Related]  

  • 36. An integrated and comparative study of the antiviral effects and other biological properties of the polyinosinic-polycytidylic acid duplex and its mismatched analogues. III. Chronic effects and immunological features.
    Carter WA; O'Malley J
    Mol Pharmacol; 1976 May; 12(3):440-53. PubMed ID: 180397
    [No Abstract]   [Full Text] [Related]  

  • 37. Recurrent secondary frosted branch angiitis after toxoplasmosis vasculitis.
    Oh J; Huh K; Kim SW
    Acta Ophthalmol Scand; 2005 Feb; 83(1):115-7. PubMed ID: 15715571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Branch retinal arterial occlusion associated with toxoplasmic chorioretinitis.
    Küçükerdönmez C; Yilmaz G; Akova YA
    Ocul Immunol Inflamm; 2004 Sep; 12(3):227-31. PubMed ID: 15385198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental vaccinial keratoconjunctivitis. Effect of an interferon inducer (polyI:C).
    Moschini GB; O JO
    Arch Ophthalmol; 1972 Feb; 87(2):211-5. PubMed ID: 5057871
    [No Abstract]   [Full Text] [Related]  

  • 40. [Detection of IgM antibodies in immunized rabbits and toxoplasmic retinochoroiditis].
    Oniki S
    Nippon Ganka Gakkai Zasshi; 1983; 87(11):1242-9. PubMed ID: 6670650
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.